-
Proposed Joint Venture to Produce and Sell Cuban Vaccines to Treat Cancer Seeks Investors
A joint venture between the Roswell Park Cancer Institute in Buffalo, New York, and the Center for Molecular Immunology in Havana could open its doors to new U.S. investors as early as April.
- Categories
- Health Care, Investing
- Region
- Latin America
- Tags
- vaccines
-
This Mysterious $2 Billion Biotech Is Revealing the Secrets Behind Its New Drugs and Vaccines
In a recent morning meeting of scientific leaders at Moderna Therapeutics, conversation swerved toward the philosophical. Biochemist Melissa Moore, recently hired to head RNA research at the Boston-area biotech, had something on her mind: hype.
- Categories
- Health Care
- Tags
- vaccines
-
Zika Vaccine Could Be Delayed, Unaffordable After US Army Grants Exclusive Rights to Pharma Company
The U.S. Army’s plan to grant exclusive rights to a promising Zika vaccine to a major pharmaceutical company has raised questions about whether that threatens its future affordability and availability to people in developing countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Doctors Without Borders Objects to Sanofi Receiving an Exclusive License for a Zika Vaccine
Doctors Without Borders (MSF) on Monday objected to the US government’s granting of an exclusive patent license to Sanofi Pasteur for a developing Zika vaccine, though Sanofi fired back on Tuesday explaining the risks of developing such a vaccine.
- Categories
- Health Care
-
Drugmakers in Davos Shift Focus to Chronic Diseases of Poor
Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest an initial $50 million over three years to fight cancer and other non-communicable diseases in poor countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Donors and Drug Makers Offer $500 Million to Control Global Epidemics
Stung by the lack of vaccines to fight the West African Ebola epidemic, a group of prominent donors announced Wednesday that they had raised almost $500 million for a new partnership to stop epidemics before they spiral out of control.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Social Business Roundup: Building Our Immunity to Anti-Vaxxers, Solar Loans With a Side of Health, and SRI Goes Robo
There’s a crisis of trust in the world, some of it well earned – and some, like skepticism about vaccines, completely unwarranted. We cover an alarming uptick in the anti-vax movement's profile, an effort to pair solar loans with health care in Ghana, and the emergence of "robo-SRI" in this news roundup.
- Categories
- Energy, Health Care, Investing, Social Enterprise, Technology
- Tags
- ESG, impact investing, solar, vaccines
-
Social Business Roundup: A New Leader at Rockefeller, a New Investment in Global Health, and a New Mobile Money Frontrunner in India
When Raj Shah left USAID as its administrator in 2015, he went on to form – not a charity, not an NGO – but a private equity fund, Latitude Capital, which invests power and infrastructure projects in emerging markets. Now that he's been named president of the Rockefeller Foundation, what course will Shah chart? We cover that question, and several other intriguing developments, in our social business roundup.
- Categories
- Health Care, Investing
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.